Literature DB >> 21576648

HDACs and hypertrophy, kinases and cancer.

Berdymammet Hojayev, Joseph A Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21576648      PMCID： PMC3667604          DOI： 10.1161/CIRCULATIONAHA.111.032441

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  19 in total

Review 1.  Mixed signals in heart failure: cancer rules.

Authors:  Masahiko Hoshijima; Kenneth R Chien
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.

Authors:  Rusty L Montgomery; Christopher A Davis; Matthew J Potthoff; Michael Haberland; Jens Fielitz; Xiaoxia Qi; Joseph A Hill; James A Richardson; Eric N Olson
Journal:  Genes Dev       Date:  2007-07-15       Impact factor: 11.361

Review 3.  Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.

Authors:  Hui Cheng; Thomas Force
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

4.  Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.

Authors:  Gwang Hyeon Eom; Young Kuk Cho; Jeong-Hyeon Ko; Sera Shin; Nakwon Choe; Yoojung Kim; Hosouk Joung; Hyung-Seok Kim; Kwang-Il Nam; Hae Jin Kee; Hyun Kook
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

Review 5.  Role of histone deacetylases and their inhibitors in cancer biology and treatment.

Authors:  Jan H Beumer; Hussein Tawbi
Journal:  Curr Clin Pharmacol       Date:  2010-08

6.  HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.

Authors:  Bin Zheng; Mei Han; Ya-Nan Shu; Ying-Jie Li; Sui-Bing Miao; Xin-Hua Zhang; Hui-Jing Shi; Tian Zhang; Jin-Kun Wen
Journal:  Cell Res       Date:  2011-03-08       Impact factor: 25.617

7.  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.

Authors:  Chinmay M Trivedi; Yang Luo; Zhan Yin; Maozhen Zhang; Wenting Zhu; Tao Wang; Thomas Floss; Martin Goettlicher; Patricia Ruiz Noppinger; Wolfgang Wurst; Victor A Ferrari; Charles S Abrams; Peter J Gruber; Jonathan A Epstein
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

8.  Regulation of histone deacetylase 2 by protein kinase CK2.

Authors:  Shih-Chang Tsai; Edward Seto
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

9.  Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors.

Authors:  Sireerat Pluemsampant; Olga S Safronova; Ken-ichi Nakahama; Ikuo Morita
Journal:  Int J Cancer       Date:  2008-01-15       Impact factor: 7.396

Review 10.  Joining the cell survival squad: an emerging role for protein kinase CK2.

Authors:  Khalil Ahmed; Delphine A Gerber; Claude Cochet
Journal:  Trends Cell Biol       Date:  2002-05       Impact factor: 20.808
View more
  1 in total

1.  Differences in Functional Expression of Connexin43 and NaV1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in Heart.

Authors:  Xian Zhang; Dakshesh Patel; Qin Xu; Richard Veenstra
Journal:  Int J Mol Sci       Date:  2018-08-04       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.